# Catalyst Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/catalyst-biosciences

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.catalystbiosciences.com
- Total disclosed funding: $78M
- Latest round: Series C (Sep 12, 2012)
- Investors on record: 8

## About

Founded in 2003 and based in South San Francisco, California, Catalyst Biosciences, Inc. is a drug discovery and development company, which develops catalytic bio-pharmaceutical products based on engineered human proteases.

## Funding rounds

- Series C, Sep 12, 2012, $13M — Burrill & Company, Essex Woodlands, Morgenthaler Ventures, Johnson & Johnson Innovation, Healthcare Ventures
- Series C, Dec 3, 2008, $40M — Burrill & Company, Essex Woodlands, HealthCare Ventures, Morgenthaler Ventures, Sofinnova Investments, Novartis Venture Fund, Johnson & Johnson Innovation
- Series B, Dec 3, 2007, $13M — Burrill & Company, HealthCare Ventures, Morgenthaler Ventures, Sofinnova Investments, Novartis Venture Fund, Research Corporation Technologies
- Series A, Oct 28, 2004, $10M — Burrill & Company, Sofinnova Investments, Novartis Venture Fund, Research Corporation Technologies

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A, Series B, Series C
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B, Series C
- Research Corporation Technologies (https://capitalatlas.ai/funds/research-corporation-technologies) — Series A, Series B
- HealthCare Ventures — Series B, Series C
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series B, Series C
- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series C
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series C